Home |  ENGLISH |  Kontakt |  Impressum |  Datenschutz |  Anmelden |  KIT

Thema4497: Unterschied zwischen den Versionen

Aus Aifbportal

Wechseln zu: Navigation, Suche
Zeile 23: Zeile 23:
 
user interface. Weaknesses resulting from the decentralization are a lower performance, and an
 
user interface. Weaknesses resulting from the decentralization are a lower performance, and an
 
increased transparency, and thus decreased confidentiality of the status of the prescription data.
 
increased transparency, and thus decreased confidentiality of the status of the prescription data.
|Beschreibung EN=This thesis examines the strengths and weaknesses of Distributed Ledger Technology, among others of blockchain, for the digitalization of German prescriptions and its process from the creation to the fulfillment
+
|Beschreibung EN=This thesis examines the strengths and weaknesses of Distributed Ledger Technology, among others of blockchain, for the digitalization of German prescriptions and its process from the creation to the fulfillment and billing in combination with a patient-specific presentation of the medication to be taken, the medication plan. It is shown that the strengths of the technology only outweigh the disadvantages if a party that is trusted by all users and that offers a client-server solution does not exist. For this purpose, a system design which complies with the current requirements is developed and evaluated. Characteristics that influence the security, transparency, usability, flexibility, further development,
and billing in combination with a patient-specific presentation of the medication to be taken,
 
the medication plan. It is shown that the strengths of the technology only outweigh the disadvantages if
 
a party that is trusted by all users and that offers a client-server solution does not exist.
 
For this purpose, a system design which complies with the current requirements is developed and evaluated.
 
Characteristics that influence the security, transparency, usability, flexibility, further development,
 
 
performance and legal compliance are considered for evaluation.
 
performance and legal compliance are considered for evaluation.
It is shown that the use of a private, permissioned Quorum blockchain in combination with a private
+
It is shown that the use of a private, permissioned Quorum blockchain in combination with a private IPFS seems most appropriate. The strength of Distributed Ledger Technology is then that it provides a
IPFS seems most appropriate. The strength of Distributed Ledger Technology is then that it provides a
+
trustworthy database in an untrusted environment. The modular structure of the system provides sufficient flexibility to integrate further developments. An adequate usability is achieved by using a straightforward user interface. Weaknesses resulting from the decentralization are a lower performance, and an increased transparency, and thus decreased confidentiality of the status of the prescription data.
trustworthy database in an untrusted environment. The modular structure of the system provides sufficient
 
flexibility to integrate further developments. An adequate usability is achieved by using a straightforward
 
user interface. Weaknesses resulting from the decentralization are a lower performance, and an
 
increased transparency, and thus decreased confidentiality of the status of the prescription data.
 
 
}}
 
}}

Version vom 12. Februar 2020, 10:15 Uhr



Design and Evaluation of an ePrescription System Based on Distributed Ledger Technology


Manon Weichert



Informationen zur Arbeit

Abschlussarbeitstyp: Master
Betreuer: Ali SunyaevTobias Dehling
Forschungsgruppe: Critical Information Infrastructures

Archivierungsnummer: 4497
Abschlussarbeitsstatus: Abgeschlossen
Beginn: 01. August 2019
Abgabe: 31. Januar 2020

Weitere Informationen

This thesis examines the strengths and weaknesses of Distributed Ledger Technology, among others of blockchain, for the digitalization of German prescriptions and its process from the creation to the fulfillment and billing in combination with a patient-specific presentation of the medication to be taken, the medication plan. It is shown that the strengths of the technology only outweigh the disadvantages if a party that is trusted by all users and that offers a client-server solution does not exist. For this purpose, a system design which complies with the current requirements is developed and evaluated. Characteristics that influence the security, transparency, usability, flexibility, further development, performance and legal compliance are considered for evaluation. It is shown that the use of a private, permissioned Quorum blockchain in combination with a private IPFS seems most appropriate. The strength of Distributed Ledger Technology is then that it provides a trustworthy database in an untrusted environment. The modular structure of the system provides sufficient flexibility to integrate further developments. An adequate usability is achieved by using a straightforward user interface. Weaknesses resulting from the decentralization are a lower performance, and an increased transparency, and thus decreased confidentiality of the status of the prescription data.